The patent cliff is often the big culprit. One might think that a one-to-one relationship could be graphed between what is happening with the patent cliff and layoffs, but that is not the case Continue reading
Pfizer Inc. PFE +0.18% plans to shrink certain segments of its U.S. sales force, in the drug maker’s latest cost-cutting move. Pfizer spokesman MacKay Jimeson said Friday the sales force would be reduced, but didn’t quantify the scope of the cuts. “As part of our strategy to allocate our resources, investments and people to the … Continue reading
Lonza Group AG (LONN) said it plans to cut 500 jobs, including 400 at a Swiss site that manufactures chemical intermediates and active pharmaceutical ingredients. Most of the job losses will come from internal transfers, natural attrition, early retirements and by not extending temporary contracts, the Swiss supplier to the pharmaceutical industry said today in … Continue reading
Profits at pharmaceutical companies have been declining or showing little growth for the last year as austerity measures across Europe lead to cuts in health care spending. Some analysts say this trend could continue until at least 2014. Budget cuts mean that many European governments are not willing to pay as much for pills. But … Continue reading